ID-1 PROMOTES REENDOTHELIALIZATION IN THE EARLY PHASE AFTER VASCULAR INJURY THROUGH ACTIVATION OF NFKB/SURVIVIN SIGNALING PATHWAY ArticleLi W., Du D., Li Y.Drug Design, Development and Therapy. Vol. 13. 2019. P.. 3799-3811
